Jefferies Financial Group's Rating of West Pharmaceutical Services on 11/2/2026

On November 2, 2026, Jefferies Financial Group updated its outlook on West Pharmaceutical Services (NYSE:WST) with the action "Reiterated Rating", keeping a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Jefferies Financial Group Inc.

DateCompanyAction
11/16/2026
Illumina, Inc. stock logo
ILMN
Illumina
Set Price Target
11/16/2026
iQIYI, Inc. Sponsored ADR stock logo
IQ
iQIYI
Set Price Target
11/16/2026
KE Holdings Inc. Sponsored ADR stock logo
BEKE
KE
Reiterated Rating
11/16/2026
AbCellera Biologics Inc. stock logo
ABCL
AbCellera Biologics
Reiterated Rating
11/16/2026
AppLovin Corporation stock logo
APP
AppLovin
Set Price Target
11/16/2026
Target Corporation stock logo
TGT
Target
Reiterated Rating
More Ratings From Jefferies Financial Group Inc.